Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ALL: a Children's Oncology Group (COG) study

Saved in:
Bibliographic Details
Published in:British journal of haematology 2012-05, Vol.157 (4), p.507-510
Main Authors: Chang, Bill H., Willis, Stephanie G., Stork, Linda, Hunger, Stephen P., Carroll, William L., Camitta, Bruce M., Winick, Naomi J., Druker, Brian J., Schultz, Kirk R.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Antineoplastic Agents - therapeutic use
Base Sequence
BCR-ABL1
Benzamides
Child
Child, Preschool
childhood
Drug Resistance, Neoplasm - genetics
Fusion Proteins, bcr-abl - genetics
Humans
Imatinib Mesylate
Infant
leukaemia
Male
Mutation
mutations
Philadelphia Chromosome
Piperazines - therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics
Pyrimidines - therapeutic use
Recurrence
Young Adult
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/j.1365-2141.2012.09039.x